Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on November 1, 2000

TABLE OF CONTENTS

Hyper links are part of the Docket  title - not all dockets/documents are linked.

NOTE:  Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE]  [ ITEM CODES ]

 
92N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992 *
94P-0036 Req labeling of trans fatty acid & prohibit deceptive claims *
98P-0203 Eliminate Forced Molting of Laying Birds*
99D-5435 Draft Guidance for Industry on Photosafety Testing *
99P-5215 Provisions of Title 21 of the Code of Federal Regulations *
00D-0186 M4 Common Technical Document;InterNatl Confern on Harmonisat *
00D-1418 Q7A ICH Good Manufacturing Practice Guide for Active Pharmac *
00N-1409 Revision of the Identification of the Ionotophoresis*
00N-1449 Changes to an Approved NDA or ANDA;Agency Information Collec *
00N-1460 Salmonella Enteritidis Research Public Meeting*
00P-1499 Remove alosetron (Lotronex) from the market*
00P-1550 Approve ANDA for Cefuroxime Axetil Products*

92N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992

CH 1 Health Industry Distributers Association Vol#: 6

94P-0036 Req labeling of trans fatty acid & prohibit deceptive claims

C 2181 C Kapp Vol#: 64

C 2182 General Mills Vol#: 64

C 2183 General Mills Vol#: 64

C 2184 Fred R Selarge Vol#: 64

EMC 484 William Welborn Vol#: 64

98P-0203 Eliminate Forced Molting of Laying Birds

C 1954 Janet Tait Vol#: 47

C 1955 Allyson B Wright Vol#: 47

99D-5435 Draft Guidance for Industry on Photosafety Testing

SUP 1 Michael Caswell Vol#: 1

99F-2673 Irradiation in the Production, Processing & Handling of Food

BKG 1 BACKGROUND MATERIAL Vol#: 1

NFR 1 Vol#: 1

99P-2630 Establish a Daily Value for "added sugars"

C 566 Lyn Verthein Vol#: 26

C 567 Eleanore M Carberry Vol#: 26

C 568 Bonnie L Smith Vol#: 26

EMC 407 Paige Lawlis-Dixon Vol#: 26

EMC 408 Karen Sanchirico Vol#: 26

EMC 409 Alan & Kay Robinson Vol#: 26

EMC 410 Deborah Thom Vol#: 26

EMC 411 Mark Goldman Vol#: 26

EMC 412 Jack Thach Vol#: 26

EMC 413 No signature (CHS9) Vol#: 26

99P-5215 Provisions of Title 21 of the Code of Federal Regulations

LET 3 Assn of American Physicians & Surgeon et Vol#: 1

00D-0186 M4 Common Technical Document;InterNatl Confern on Harmonisat

EMC 1 Ministry of Health & Welfare, JPMA Vol#: 2

00D-1418 Q7A ICH Good Manufacturing Practice Guide for Active Pharmac

ECT 6 TAKEDA CHEMICAL INDUSTRIES, LTD. Vol#: 2

ECT 7 Yamanouchi Pharmaceutical Co., Ltd. Vol#: 2

ECT 8 Sumitomo Pharmaceuticals Co., Ltd. Vol#: 2

ECT 9 Fujisawa Pharmaceutical Co.Ltd. Vol#: 2

ECT 10 KYOWA HAKKO KOGYO CO.,LTD. Vol#: 2

ECT 11 Sankyo Company, Ltd. Vol#: 2

ECT 12 TANABE SEIYAKU CO.,LTD. Vol#: 2

ECT 13 Taisho Pharmaceutical Co., Ltd. Vol#: 2

ECT 14 Eisai Co.,LTD.Kashima Plant Vol#: 2

ECT 15 Suntory Bio-Pharma Tech Center Vol#: 2

00N-1200 Dietary Supplements Containing Ephedrine Alkaloids

EC 9 CA Depart, of Hlth Services, Food and Dr Vol#: 68

EC 10 Association of Food and Drug Officials Vol#: 68

EC 11 Texas Department of Health Vol#: 68

00N-1364 Prescription Drug User Fee Act (PDUFA) Public Meeting

EC 22 American Society of Health-System Pharma Vol#: 3

00N-1409 Revision of the Identification of the Ionotophoresis

C 1 Wescor Inc Vol#: 1

M 1 HFZ-1 Extend Comment Period to 12/19/00 Vol#: 1

00N-1449 Changes to an Approved NDA or ANDA;Agency Information Collec

C 1 Pharmacia Corporation Vol#: 1

00N-1460 Salmonella Enteritidis Research Public Meeting

C 4 Kate Simon Vol#: 1
 

00N-1503 Agency Information Collection:Orphan Drugs

EC 2 no Vol#: 1
 

00N-1511 Petition for Administrative Reconsideration of Action

EC 1 Number Not Used Vol#: 1

00P-1499 Remove alosetron (Lotronex) from the market

SUP 1 Public Citizen Health Research Group Vol#: 1

00P-1550 Approve ANDA for Cefuroxime Axetil Products

SUP 1 Glaxo Welcome Inc Vol#: 2